Congenital hypofibrinogenemia and pregnancy, obstetric and hematological management.
A 27-year-old pregnant woman with severe congenital hypofibrinogenemia was studied from the 18th to the 40th week of pregnancy, after which she had a normal delivery. The results of the quantitative and qualitative fibrinogen studies done on the patient made it possible to rule out associated dysfibrinogenemia. No variations in the concentration and function of fibrinogen were observed during gestation. The only treatment given was a transfusion of fresh plasma prior to delivery. The importance of fibrinogen in maintaining normal placental insertion and the obstetric management of predelivery and delivery are discussed.
Gilabert
J
J
Department of Obstetrics and Gynecology, Hospital La Fe, Valencia, Spain.
Regañon
E
E
Vila
V
V
Baamonde
A
A
Villa
P
P
Aznar
J
J
Galbis
M
M
D000328:Adult; D000347:Afibrinogenemia / Q000150:complications*; D001780:Blood Coagulation Tests; D001798:Blood Proteins / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D010949:Plasma; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*
D001798:Blood Proteins; D005340:Fibrinogen